Comparison of Balloon Dilation and Laser Eustachian Tuboplasty in Patients with Eustachian Tube Dysfunction: A Meta‐analysis

Wang, Tang Chuan; Lin, Chia Der; Shih, Tzu Ching; Chung, Hsiung Kwang; Wang, Ching Yuang; Tsou, Yung An; Huang, Ching Hsuan; Tsai, Ming‐Hsui

doi:10.1177/0194599817753609

Cited by 20 publications

(13 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some groups reported that 66–72% of patients achieved normal middle ear aeration following laser tuboplasty at 1 year [ 2 – 4 ]. Although balloon tuboplasty has some advantages, such as a short operation time, good tolerability, lack of mucosal injury of the anterior tubal wall and significant complications, as well as improvements in long-term subjective and objective measures [ 6 – 9 ], Wang et al [ 21 ] reported that Valsalva maneuver results were similar between the balloon and laser procedures.…”

Section: Discussionmentioning

confidence: 99%

Microwave ablation eustachian tuboplasty: A preliminary investigation with long-term follow-up

Lou¹,

Lou

Sun³

et al. 2021

Journal of Otolaryngology - Head & Neck Surgery

View full text Add to dashboard Cite

Objectives This study was performed to evaluate the efficacy of microwave ablation (MWA) eustachian tuboplasty for the treatment of patients with retracted tympanic membrane (TM) due to eustachian tube dysfunction (ETD). Methods This was a prospective study of 20 patients with ETD (middle ear atelectasis) who underwent MWA eustachian tuboplasty. Outcomes included the ability to perform a Valsalva maneuver, audiometry results, tympanometry results, ETD Questionnaire (ETDQ-7) score, and TM status. Results Eighteen patients (18 ears) were included in this study. There were statistically and clinically significant improvements in the mean ETDQ-7 score at 6 months postoperatively (change in mean score of 16.7 ± 3.6, P < 0.001) and at 30 months postoperatively (change in mean score of 18.9 ± 2.9, P < 0.001). Type A tympanogram was obtained in 27.8% of patients (5/18) at 6 months postoperatively, and in 77.7% at 30 months postoperatively. A Valsalva maneuver was possible in 72.2% of patients at 6 months postoperatively and in 88.9% of patients at 30 months postoperatively. In addition, the ears of 13 patients (72.2%) showed both normal tympanograms and TM at 30 months postoperatively. Interestingly, 38.5% of patients (5/13) exhibited complete sclerosis of the pars tensa. None of the patients experienced severe MWA-related complications during follow-up. Conclusions MWA eustachian tuboplasty is a feasible alternative to conventional tuboplasty, and can improve subjective and objective outcomes in patients with ETD for up to 30 months following treatment. In addition, this study showed that the extent of sclerotic plaque increased over time, whereas the extents of atrophy and tensa retraction decreased following tuboplasty in most patients. Graphical abstract

show abstract

Section: Discussionmentioning

confidence: 99%

Microwave ablation eustachian tuboplasty: A preliminary investigation with long-term follow-up

Lou¹,

Lou

Sun³

et al. 2021

Journal of Otolaryngology - Head & Neck Surgery

View full text Add to dashboard Cite

show abstract

“…A meta-analysis of prospective and retrospective studies comparing Eustachian tube balloon dilatation and laser Eustachian tuboplasty in Taiwan showed no inferiority of Eustachian tube balloon dilatation results, but also noted the need for further studies to assess its efficacy. 17…”

Section: Discussionmentioning

confidence: 99%

Eustachian tube balloon dilatation: a cross-sectional, survey-based study of 137 UK consultants

Koumpa

Bowles

et al. 2019

J. Laryngol. Otol.

View full text Add to dashboard Cite

ObjectiveTo explore the opinions of the UK consultant body on endoscopic Eustachian tube balloon dilatation in the context of Eustachian tube dysfunction.MethodA 10-question online survey was distributed to ENT consultants currently practising in the UK (July–September 2018).ResultsA total of 137 ENT consultants responded. Twenty-three per cent reported experience of Eustachian tube balloon dilatation, with a further 10 per cent planning to start performing the procedure. Of those performing the procedure, 16 per cent had more than two years’ experience. Thirty-two per cent were performing zero to five procedures a year. Eustachian tube balloon dilatation was primarily conducted to treat Eustachian tube dysfunction symptoms, as well as retraction pockets, baro-challenge-induced Eustachian tube dysfunction and otitis media with effusion. The most common reason for not undertaking Eustachian tube balloon dilatation was insufficient evidence of efficacy (65 per cent). Seventy-two per cent of consultants thought that creating a national database for audit and monitoring purposes would benefit the specialty.ConclusionThe majority of UK ENT consultants do not practise Eustachian tube balloon dilatation, citing a lack of high-level evidence to support its use. A national database for auditing and research could facilitate the creation of guidelines.

show abstract

“…Findings of this systematic review are in line with some of the previously published literature, demonstrating little evidence about Laser Eustachian tuboplasty or Microdebrider Eustachian tuboplasty as a treatment for adult Eustachian tube dysfunction. 4,5 On the contrary, the findings of all studies reporting Laser and Microdebrider Eustachian tuboplasty as an effective treatment are in 6 This recent review analysed 13 uncontrolled studies dealing with 1063 patients. 6 This review concluded improvement in the symptoms of Eustachian tube dysfunction with the use of Balloon dilatation and Laser Eustachian tuboplasty.…”

Section: Comparison Of the Findings Of This Review With The Previousl...mentioning

confidence: 99%

“…4,5 On the contrary, the findings of all studies reporting Laser and Microdebrider Eustachian tuboplasty as an effective treatment are in 6 This recent review analysed 13 uncontrolled studies dealing with 1063 patients. 6 This review concluded improvement in the symptoms of Eustachian tube dysfunction with the use of Balloon dilatation and Laser Eustachian tuboplasty. 6 But this conclusion was based on low-level evidence.…”

Section: Comparison Of the Findings Of This Review With The Previousl...mentioning

confidence: 99%

Laser vs microdebrider eustachian tuboplasty for the treatment of chronic adult eustachian tube dysfunction: A systematic review

Jamil

Izzat

2021

World j. otorhinolaryngol.-head neck surg.

View full text Add to dashboard Cite

Objectives Multiple treatments are described in the literature for the treatment of chronic Eustachian tube dysfunction but high-level quality evidence seems missing to support these treatments. This systematic review aimed to determine and compare the safety and efficacy of Laser Eustachian tuboplasty and Microdebrider Eustachian tuboplasty as a treatment for long-term Eustachian tube dysfunction. Data sources A total of 12 electronic databases were searched up to April 2018 for published and unpublished literature in the English language. References of included studies were checked. Methods A systematic review was undertaken. Outcomes assessed were: primary outcomes-subjective improvement in symptoms (ETDQ-7), audiometric improvement of hearing, improvement of negative middle ear pressure noticed in tympanometry, objective improvement of tympanic membrane retraction. Secondary outcomes were-the ability to auto-insufflate Eustachian tube i.e. Valsalva manoeuvre, improved quality of life, passive tubal opening, tubomanometry, swallowing test, reduction in mucosal inflammation of Eustachian tube orifice in the nose, complications from the procedure, the need for further procedures. Results are reported in a narrative synthesis as a meta-analysis was not possible due to heterogeneous data. Results Three studies were included. All included studies were small-scale case series (13–38 participants). Studies were conducted outside the UK. Subjective and objective improvement of Eustachian tube function was reported in all studies. But all included studies were at high risk of bias and subject to multiple limitations. No major complications were reported in either study. Conclusions Based on current evidence, it is not possible to recommend the clinical use of either of these two interventions i.e. Laser or Microdebrider Eustachian tuboplasty. Lack of controlled studies was identified as a gap in the evidence. Future research should be directed toward designing randomised controlled trials. These trials should use strict standard methodology and reporting criteria. Future trials should make use of consensus statement document about Eustachian tube dysfunction definition, diagnostic methods, and outcome assessment criteria to design clinical trials.

show abstract

Comparison of Balloon Dilation and Laser Eustachian Tuboplasty in Patients with Eustachian Tube Dysfunction: A Meta‐analysis

Cited by 20 publications

References 30 publications

Microwave ablation eustachian tuboplasty: A preliminary investigation with long-term follow-up

Microwave ablation eustachian tuboplasty: A preliminary investigation with long-term follow-up

Eustachian tube balloon dilatation: a cross-sectional, survey-based study of 137 UK consultants

Laser vs microdebrider eustachian tuboplasty for the treatment of chronic adult eustachian tube dysfunction: A systematic review

Contact Info

Product

Resources

About